DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1,130.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 266,884 shares of the medical instruments supplier’s stock after buying an additional 245,199 shares during the period. Chicago Partners Investment Group LLC’s holdings in DENTSPLY SIRONA were worth $2,517,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of XRAY. BlackRock Inc. acquired a new stake in DENTSPLY SIRONA during the second quarter valued at $283,405,000. Southpoint Capital Advisors LP acquired a new position in DENTSPLY SIRONA in the 1st quarter worth about $116,000,000. Edmond DE Rothschild Holding S.A. purchased a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth about $47,780,000. Paradigm Capital Management Inc. NY acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $39,775,000. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of DENTSPLY SIRONA by 31.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,559,388 shares of the medical instruments supplier’s stock valued at $41,284,000 after buying an additional 850,261 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Down 6.2%

Shares of XRAY stock opened at $9.46 on Friday. The stock’s 50 day simple moving average is $9.60 and its 200 day simple moving average is $11.28. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. DENTSPLY SIRONA Inc. has a twelve month low of $8.14 and a twelve month high of $14.76. The company has a market capitalization of $1.89 billion, a price-to-earnings ratio of -15.26, a PEG ratio of 1.27 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02). DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. The company had revenue of $836.00 million for the quarter, compared to the consensus estimate of $861.68 million. During the same period in the previous year, the company earned $0.37 EPS. The firm’s revenue for the quarter was down 7.5% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. As a group, research analysts predict that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on XRAY shares. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday, October 30th. Barclays raised their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research report on Monday, August 24th. Piper Sandler decreased their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, October 9th. Mizuho dropped their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Thursday, October 22nd. Finally, Barrington Research cut their price target on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 26th. Three research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $12.64.

More DENTSPLY SIRONA News

Here are the key news stories impacting DENTSPLY SIRONA this week:

• Positive Sentiment: Growth at Wellspect provided some support amid weakness elsewhere in the business. XRAY Stock Declines as Q3 Earnings & Sales Miss Estimates, Outlook Cut
• Negative Sentiment: Q3 adjusted earnings of $0.29 per share fell short of the $0.31 analyst consensus, while revenue of $836 million missed the roughly $862 million estimate. Revenue declined about 7.5% year over year, and EPS was lower than the $0.37 reported a year earlier. Third-quarter and nine-month results
• Negative Sentiment: The company cut its 2026 adjusted EPS guidance to $1.20–$1.30, below the $1.47 analyst consensus, and forecast revenue of $3.5 billion versus expectations of $3.6 billion. The lower outlook reinforces concerns about continued demand weakness. XRAY Stock Declines as Q3 Earnings & Sales Miss Estimates, Outlook Cut

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.